Drug Trial Radar · NCT00103402
Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Last checked: Nov 20, 2026Latest source record: Jun 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
272
Actual
Start
Feb 2005
Primary completion
Jan 2008
Study completion Jan 2008
Sponsor
- Sponsor type
- NIH
- Collaborators
- University of Pennsylvania
- First posted
- Feb 8, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this randomized clinical trial is to evaluate the efficacy and safety of the alpha adrenergic blocker Alfuzosin (Uroxatral) in men with relatively new onset of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Alfuzosin is a once daily (10 mg capsule), FDA approved medication for an indication in benign prostatic hyperplasia (BPH). The effectiveness of alfuzosin in improving lower urinary tract symptoms in patients with BPH has been documented in a number of placebo-controlled studies. A number of small studies have also suggested that alfuzosin ameliorates CP/CPPS symptoms through a similar alpha-blockade mechanism. This study will enable further testing of this hypothesis
Conditions
- Prostatitis
Interventions
AlfuzosinDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Decline in Total Score ≥4 for the NIH-CPSI Total Score From Baseline to 12 WeeksTime frame: Baseline and 12 weeks
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
David Geffen School of Medicine at UCLA
Los Angeles, California
Stanford University Medical Center
Stanford, California
Northwestern U. Feinberg School of Medicine
Chicago, Illinois
University of Maryland
Baltimore, Maryland
Harvard Medical School- Massachusetts General Hospital
Boston, Massachusetts
University of Mississippi Medical Center
Jackson, Mississippi
Cleveland Clinic
Cleveland, Ohio
Temple University
Philadelphia, Pennsylvania
University of Washington- Harborview Medical Center
Seattle, Washington
Queen's University
Kingston, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.